« Return to News | CROs/Service Providers

Sartorius opens German production facility for bioreactors

Friday, September 14, 2012 12:19 PM

Sartorius, the Germany-based international laboratory and process technology provider, has officially opened its new plant in Guxhagen, Germany, for the manufacture of bioreactors.

After approximately one year of construction and $23.5 million, the new building will now manufacture bioreactors and further production equipment for customers in the biopharmaceutical industry. Covering a total area of nearly 10,000 square feet, the new building complex provides space for a high-tech manufacturing hall and offices for 240 employees. The building owner is Robos GmbH, from which Sartorius has rented the premises in a long-term lease.

"The new plant enables us to substantially enhance our manufacturing processes and creates additional capacity for us in view of the rising demand for biopharmaceutical production equipment,” said Joachim Kreuzburg, CEO and executive board chairman, Sartorius. “As a result, we are optimally prepared for further expansion, especially for single-use bioreactors.”

Sartorius has moved all operations from its former bioreactor production facility in Melsungen, Germany, where it had reached maximum capacity limits.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.